Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane D Miller

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Physiological Genomics|September 24, 2017
Role of lysophosphatidic acid and its receptors in the kidneyFrank Park, Duane D Miller
Oncoscience|January 19, 2018
Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancerRamesh Narayanan, Suriyan Ponnusamy, Duane D Miller
International Journal of Molecular Sciences|March 6, 2021
Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal SystemSicheng Zhang, Duane D Miller, Wei Li
Drug Discovery Today|December 10, 2021
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspectiveJiaxing Wang, Duane D Miller, Wei Li
Future Medicinal Chemistry|November 20, 2012
Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agentsShivaputra A Patil, Renukadevi Patil, Duane D Miller
Chinese Journal of Natural Medicines|August 3, 2015
The role of vitamin D in cancer preventionRachel A Ness, Duane D Miller, Wei Li
Current Medicinal Chemistry|July 16, 2009
Solid phase synthesis of biologically important indolesShivaputra A Patil, Renukadevi Patil, Duane D Miller
Current Medicinal Chemistry|November 27, 2020
Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug ResistanceHongmei Cui, Kinsie Arnst, Duane D Miller, et al.
Molecular Cancer Therapeutics|November 20, 2013
Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanomaJin Wang, Jianjun Chen, Duane D Miller, et al.
Frontiers in Pharmacology|April 12, 2021
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 MelanomaHongmei Cui, Qinghui Wang, Duane D Miller, et al.
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Physiological Genomics|September 24, 2017
Role of lysophosphatidic acid and its receptors in the kidneyFrank Park, Duane D Miller
Oncoscience|January 19, 2018
Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancerRamesh Narayanan, Suriyan Ponnusamy, Duane D Miller
International Journal of Molecular Sciences|March 6, 2021
Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal SystemSicheng Zhang, Duane D Miller, Wei Li
Drug Discovery Today|December 10, 2021
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspectiveJiaxing Wang, Duane D Miller, Wei Li
Future Medicinal Chemistry|November 20, 2012
Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agentsShivaputra A Patil, Renukadevi Patil, Duane D Miller
Chinese Journal of Natural Medicines|August 3, 2015
The role of vitamin D in cancer preventionRachel A Ness, Duane D Miller, Wei Li
Current Medicinal Chemistry|July 16, 2009
Solid phase synthesis of biologically important indolesShivaputra A Patil, Renukadevi Patil, Duane D Miller
Current Medicinal Chemistry|November 27, 2020
Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug ResistanceHongmei Cui, Kinsie Arnst, Duane D Miller, et al.
Molecular Cancer Therapeutics|November 20, 2013
Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanomaJin Wang, Jianjun Chen, Duane D Miller, et al.
Frontiers in Pharmacology|April 12, 2021
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 MelanomaHongmei Cui, Qinghui Wang, Duane D Miller, et al.
Pageof 25